GlassScriptPhysician profile
Sean Allen Roth
NPI 1710907092
$1,922.03
in general payments reported to CMS, 2019-2025
9 companies · $285 in 2025
The $285 reported for 2025 was more than what 82% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $90.10 · 2021: $366 · 2022: $264 · 2023: $318 · 2024: $130 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $733.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $843.29 | 2019-2025 | |
| Dentsply Sirona INC | $292.83 | 2021-2024 | Ankylos, Astra Tech Implant System, Cavitron |
| Align Technology, INC. | $237.14 | 2020-2023 | Invisalign System - Lite |
| Dmg America LLC | $213.94 | 2019-2022 | |
| Ultradent Products INC | $209.97 | 2021 | |
| Nobel Biocare USA | $44.97 | 2022-2023 | Nobelactive |
| Solventum Corporation | $42.16 | 2025 | Vanish Xt, Clinpro 5000, 3m Clinpro |
| 3m Company | $20.04 | 2023 | Filtek, 3m Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Envista Holdings Corporation | $17.69 | 2025 | Round Bur #6 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.